Letter to the editor: Extent of pleural effusion on chest radiograph is associated with failure of high-flow nasal cannula oxygen therapy

2017 ◽  
Vol 41 ◽  
pp. 326
Author(s):  
Mediha Turktan ◽  
Dilek Ozcengiz ◽  
Antonio M. Esquinas
2016 ◽  
Vol 32 ◽  
pp. 165-169 ◽  
Author(s):  
Yasutaka Koga ◽  
Kotaro Kaneda ◽  
Ichiko Mizuguchi ◽  
Takashi Nakahara ◽  
Takashi Miyauchi ◽  
...  

2021 ◽  
Author(s):  
Paola Papoff ◽  
Elena Caresta ◽  
Stefano Luciani ◽  
Alessandra Pierangeli ◽  
Carolina Scagnolari ◽  
...  

2018 ◽  
Vol 18 (12) ◽  
pp. 1652-1653 ◽  
Author(s):  
Filippo Luca Fimognari ◽  
Massimo Rizzo ◽  
Olga Cuccurullo ◽  
Giovanna Cristiano ◽  
Roberto Ricchio ◽  
...  

2020 ◽  
Vol 12 (1) ◽  
pp. 1-5
Author(s):  
Ibtesam A. Hilmi ◽  
Philip C. Carullo ◽  
Dennis P. Phillips ◽  
Ezeldeen Abuelkasem

The physiologic benefits of high-flow nasal cannula (HFNC) therapy are well documented in the intensive care literature, yet only a handful of case reports describe its perioperative use. Our single center experience explored comprehensive applications of HFNC in the perioperative setting. Over a ten-month period, HFNC was used in the care of 85 medically complex patients either as an adjuvant or main oxygen therapy during induction of general anesthesia, maintenance of deep intraoperative sedation, and during early postoperative care. Here, we illustrate clinical scenarios in which HFNC therapy made patient care safer and describe a framework for integrating this technology into the anesthesia practice at our institution.


Sign in / Sign up

Export Citation Format

Share Document